Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5821-5838

  Kohl, Katrin S ^a   Ball, Leslie ^b   Gidudu, Jane ^a   Hammer, Sandra Jo ^c   Halperin, Scott ^d   Heath, Paul ^e   Hennig, Renald ^f   Labadie, Jerry ^g   Rothstein, Edward ^h   Schuind, Anne ⁱ   Varricchio, Frederick ^b   Walop, Wikke ^j  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^f Novartis Vaccine   (Germany)

^g NETHERLANDS PHARMACOVIGILANCE CENTRE LAREB   (Netherlands)

^h Pennridge Pediatric Associates   (United States)

ⁱ GLAXOSMITHKLINE   (United States)

^j PUBLIC HEALTH AGENCY OF CANADA   (Canada)

more..

Author keywords

Abscess; Adverse event; Case definition; Guidelines; Immunization

Indexed keywords

VACCINE;

ARTICLE; CASE DEFINITION; CASE STUDY; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; DRUG SAFETY; HUMAN; IMMUNIZATION; INJECTION SITE; INJECTION SITE ABSCESS; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD;

ABSCESS; ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; GUIDELINES; HUMANS; IMMUNIZATION; INJECTIONS; SAFETY;

EID: 34447282513     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.057     Document Type: Article

References (34)

1. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007) 5671-5674
2. Rothstein E., et al. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 575-585
3. Baraff L.J., Cody C.L., and Cherry J.D. DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics 73 (1984) 31-36
4. Bernier R.H., Frank J.A., and Nolan T.F. Abscesses complicating DTP vaccination. Am J Dis Child 135 (1981) 826-828
5. Centers for Disease Control and Prevention. Epidemiologic Notes and Reports - Group A Streptococcal Abscesses after DTP Immunization - Georgia. MMWR 31 (1982) 519-520 525-6
6. Church J.A., and Richards W. Recurrent abscess formation following DTP immunizations: association with hypersensitivity to tetanus toxoid. Pediatrics 75 (1985) 899-900
7. Grange J.M. Complications of Bacilli Calmette-Guerin (BCG) vaccination and immunotherapy and their management. Commun Diseases Public Health 1 (1998) 84-88
8. Greaves W.L., Hinman A.R., Facklam Rr, Allman K.C., Barrett C.J., and Stetler H.C. Streptococcal abscess following diphtheria-tetanus toxoid-pertussis vaccination. Pediatr Infec Dis 1 (1982) 388-390
9. Niederman L.G., and Marcinak J.F. Haemophilus influenzae type b abscess after diphtheria-tetanus toxoids-pertussis immunization. Pediatr Infec Dis J (1990) 597-598
10. Owensby J.E., Elliot S., Tu K., and Hernadez J.E. Cellulitis and myositis caused by Agrobacterium radiobacter and Haemophilus parainfluenzae after influenza virus vaccination. Southern Med J 90 (1997) 752-754
11. Praveeen K.N., Smikle M.F., Prabhakar P., Pande D., Johnson B., and Ashley D. Outbreak of Bacilleus Calmette-Guerin-associated lymphadenitis and abscesses in Jamaican children. Pediatr Infect Dis J 9 (1990) 890-893
12. Sakar P., and Dasgupta S. Complications of intramuscular injections in children. J Indian Med Assoc 77 (1981) 145-147
13. Simon P.A., Chen R.T., Elliott J.A., and Schwarz B. Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination. Pediatr Infec Dis J 12 (1993) 368-371
14. Smith A.L., Khan F., and DeMello W. Sterile abscess formation following plague vaccination. J R Army Med Corps 143 (1997) 116-117
15. Stetler H.C., Garbe P.L., Dwyer D.M., Facklam R.R., Orenstein W.A., West G.R., et al. Outbreaks of Group A Streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination. Pediatrics 75 (1985) 299-303
16. Stedman's Medical Dictionary. 27th ed. (2000), Lippincott, Williams & Wilkins Company, Baltimore p. 5-6
17. In: Beers M.H., Berkow R., and Burs M. (Eds). Merck Manual Diagnosis and Therapy. 17th ed. (1999), Merck & Co. 1135-1143
18. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's Principle and Practices of Infectious Diseases. 5th ed. (2000), Churchill, Livingston
19. Centers for Disease Control and Prevention. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. MMWR 40 RR10 (1991) 1-28
20. American Academy of Pediatrics. In: Pickering L.K. (Ed). 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. (2000), American Academy of Pediatrics, Elk Grove Village, IL 15
21. Ball L.K., Ball R., Kleppinger C., Kohl K., and Pratt R.D. Reports to the Vaccine Adverse Event Reporting System (VAERS) of abscesses after vaccination: clinical and microbiological features of serious reports. Proceedings of the 39th Annual Meeting of the Infectious Disease Society of America (2001) [Abstract]
22. Goto N., and Akama K. Local histopathological reactions to aluminum-adsorbed tetanus toxoid. Naturwissenschaften 71 (1984) 427-428
23. McMillan C.S., Spuge A.R.I., Hammerberg O., and Thain L.M.F. Magnetic resonance imaging for differentiating delayed-onset sterile abscess complicating vaccination form soft-tissue neoplasm: case report. Can Assoc Radiol J 51 (2000) 28-29
24. Wilhelmsen C.L., and Waag D.M. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines. Comp Med 50 (2000) 374-378
25. Borghans J.G., and Stanford J.L. Mycobacterium chelonie in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis 107 (1973) 1-8
26. Health Canada. Division of Immunization. Report of a vaccine-associated adverse event. Form HC/SC 4229 (03-96)-1. Ottawa, Ontario; 1996.
27. Marcy S.M., Kohl K.S., Dagan R., Nalin D., Blum M., Jones M.C., et al. Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation. Vaccine 22 (2004) 551-556
28. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ [last accessed February 9, 2006].
29. Council for International Organizations of Medical Sciences (CIOMS). Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm [last accessed February 9, 2006].
30. CDC. Guidelines for maintaining and managing the vaccine cold chain. MMWR 2003;52:1023-5 [last accessed January 26, 2007].
31. MMWR 2006; 55(RR15): 1-48. Also available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm?s_cid=rr5515a1_e%0d%0a [last accessed January 26, 2007].
32. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm [last accessed February 9, 2006].
33. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., and Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 9193 (1999) 1896-1900. http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006]
34. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283 15 (2000) 2008-2012. http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006]